A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Condition: AsthmaInterventions: Drug: lebrikizumab; Drug: montelukast [Singulair]; Other: placeboSponsor: Hoffmann-La RocheRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2014 Category: Research Source Type: clinical trials
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Condition: AsthmaInterventions: Drug: lebrikizumab; Drug: montelukast [Singulair]; Other: placeboSponsor: Hoffmann-La RocheRecruiting - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2014 Category: Research Source Type: clinical trials
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Condition: AsthmaInterventions: Drug: lebrikizumab; Drug: montelukast [Singulair]; Other: placeboSponsor: Hoffmann-La RocheRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2014 Category: Research Source Type: clinical trials
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Condition: AsthmaInterventions: Drug: lebrikizumab; Drug: montelukast [Singulair]; Other: placeboSponsor: Hoffmann-La RocheRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2014 Category: Research Source Type: clinical trials
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Condition: AsthmaInterventions: Drug: lebrikizumab; Drug: montelukast [Singulair]; Other: placeboSponsor: Hoffmann-La RocheRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2014 Category: Research Source Type: clinical trials
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Condition: AsthmaInterventions: Drug: lebrikizumab; Drug: montelukast [Singulair]; Other: placeboSponsor: Hoffmann-La RocheRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2014 Category: Research Source Type: clinical trials
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Condition: AsthmaInterventions: Other: Test1; Drug: lebrikizumab; Drug: montelukast [Singulair]; Other: placeboSponsor: Hoffmann-La RocheRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2014 Category: Research Source Type: clinical trials
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Condition: AsthmaInterventions: Other: Test1; Drug: lebrikizumab; Drug: montelukast [Singulair]; Other: placeboSponsor: Hoffmann-La RocheRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2014 Category: Research Source Type: clinical trials
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Condition: AsthmaInterventions: Drug: lebrikizumab; Drug: montelukast [Singulair]; Other: placeboSponsor: Hoffmann-La RocheRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2014 Category: Research Source Type: clinical trials
Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable Tablets 5mg Under Fasted Conditions
Condition: HealthyInterventions: Drug: Torrent's Montelukast Sodium Chewable Tablets 5mg; Drug: Singulair® (Montelukast Sodium) Chewable Tablets 5mgSponsors: Torrent Pharmaceuticals Limited; Torrent Pharmaceuticals LimitedCompleted - verified August 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2013 Category: Research Source Type: clinical trials